tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
US Market
ACAD
ACADIA Pharmaceuticals
RESEARCH TOOLSreports
Want to see ACAD full AI Analyst Report?

ACADIA Pharmaceuticals (ACAD) Income Statement

2,437 Followers

ACADIA Pharmaceuticals Income Statement

Last quarter (Q4 2025), ACADIA Pharmaceuticals's total revenue was $283.99M, an increase of 9.39% from the same quarter last year. In Q4, ACADIA Pharmaceuticals's net income was $273.57M. See ACADIA Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.07B$ 957.80M$ 726.44M$ 517.24M$ 484.14M
Gross Profit
$ 982.51M$ 875.96M$ 680.71M$ 507.07M$ 465.00M
Operating Expenses
$ 877.70M$ 645.16M$ 754.09M$ 730.66M$ 635.44M
Depreciation and Amortization
$ 0.00$ 15.88M$ 5.55M$ 2.03M$ 3.34M
EBITDA
$ 138.90M$ 100.16M$ -67.83M$ -221.57M$ -167.09M
Operating Income
$ 104.81M$ 230.79M$ -73.38M$ -223.60M$ -170.44M
Other Income/Expenses
$ 34.09M$ 27.28M$ 22.34M$ 10.15M$ 2.92M
Pretax Income
$ 138.90M$ 258.07M$ -51.04M$ -213.44M$ -167.52M
Net Income
$ 391.00M$ 226.45M$ -61.29M$ -215.97M$ -167.87M
Per Share Metrics
Basic EPS
$ 2.32$ 1.37$ -0.37$ -1.34$ -1.05
Diluted EPS
$ 2.29$ 1.36$ -0.37$ -1.34$ -1.05
Weighted Average Shares Outstanding
 169.34M 165.72M 163.82M 161.68M 160.49M
Weighted Average Shares Outstanding (Diluted)
 171.36M 166.36M 163.82M 161.68M 160.49M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History